ArticleMicrobiology spectrum2017
U.S. Regulatory Considerations for Development of Live Biotherapeutic Products as Drugs.
Sheila M Dreher-Lesnick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it